Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1975 1
1977 1
1979 1
1980 1
1981 1
1983 1
1984 2
1985 3
1987 1
1989 4
1990 2
1991 1
1992 6
1993 3
1994 5
1995 8
1996 9
1997 5
1998 10
1999 2
2000 5
2001 2
2002 3
2003 2
2004 7
2005 1
2006 3
2007 7
2008 6
2009 7
2010 8
2011 3
2012 8
2013 11
2014 10
2015 5
2016 9
2017 2
2018 6
2019 6
2020 8
2021 8
2022 10
2023 10
2024 15
2025 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.
PD Med Collaborative Group; Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE. PD Med Collaborative Group, et al. Lancet. 2014 Sep 27;384(9949):1196-205. doi: 10.1016/S0140-6736(14)60683-8. Epub 2014 Jun 11. Lancet. 2014. PMID: 24928805 Clinical Trial.
Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.
Gray R, Patel S, Ives N, Rick C, Woolley R, Muzerengi S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE; PD MED Collaborative Group. Gray R, et al. JAMA Neurol. 2022 Feb 1;79(2):131-140. doi: 10.1001/jamaneurol.2021.4736. JAMA Neurol. 2022. PMID: 34962574 Free PMC article. Clinical Trial.
Targeting the NLRP3 Inflammasome in Glaucoma.
Coyle S, Khan MN, Chemaly M, Callaghan B, Doyle C, Willoughby CE, Atkinson SD, Gregory-Ksander M, McGilligan V. Coyle S, et al. Biomolecules. 2021 Aug 19;11(8):1239. doi: 10.3390/biom11081239. Biomolecules. 2021. PMID: 34439904 Free PMC article. Review.
Electroencephalographic evolution of SEEG-associated intracerebral haemorrhage.
Mahizhnan MM, Gillinder L, Craig D, Wensley I, Coyle S, Ferguson S, Papacostas J, McGonigal A. Mahizhnan MM, et al. Among authors: coyle s. Neurophysiol Clin. 2022 Nov;52(6):486-488. doi: 10.1016/j.neucli.2022.10.001. Epub 2022 Oct 22. Neurophysiol Clin. 2022. PMID: 36283913 No abstract available.
Polycarbonate Heat Molding for Soft Lithography.
Sonmez UM, Coyle S, Taylor RE, LeDuc PR. Sonmez UM, et al. Among authors: coyle s. Small. 2020 Apr;16(16):e2000241. doi: 10.1002/smll.202000241. Epub 2020 Mar 29. Small. 2020. PMID: 32227442
The myth that shames us all.
Coyle S, Elverson J, Harlow T, Jordan A, McNamara P, O'Neill C, Quibell R, Regnard C, Spiller J, Stephenson J. Coyle S, et al. Lancet. 2018 Oct 6;392(10154):1196. doi: 10.1016/S0140-6736(18)31876-2. Lancet. 2018. PMID: 30319108 No abstract available.
NLRP3 Inflammasome Inhibition by the Novel Bispecific Antibody InflamAb Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.
Delfos L, Depuydt MAC, Chemaly M, Coyle S, Schaftenaar FH, van Santbrink PJ, Lindenbergh PP, Bernabé Kleijn MNA, Costello C, Power CA, Coll R, Peace A, Gregory-Ksander M, Foks AC, Kuiper J, McGilligan V, Bot I. Delfos L, et al. Among authors: coyle s. JACC Basic Transl Sci. 2025 Jun;10(6):826-840. doi: 10.1016/j.jacbts.2024.12.012. Epub 2025 Mar 5. JACC Basic Transl Sci. 2025. PMID: 40562495 Free PMC article.
228 results